Online Submissions

Already have a Username/Password for MD-Onco?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

These guidelines for authors are based on the “CSE’s White Paper on Promotion Integrity in Scientific Journal Publications”, 2012 Update, and the “ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals”, December 2016.

The journal accepts original articles, reviews, lectures, and clinical case descriptions not previously published in other scientific publications.

Submissions are accepted from graduate students, candidates for academic degrees, doctoral students, specialists, and experts in the field.

The articles, which do not correspond to our rules, will be rejected.

All received articles are refereed.

Board of editors reserves the right to proofread the articles, submitted for publishing.

Editorial board does not provide author's copies of the journal. Number of the journal can be obtained on a general basis, see information on the website.

I. Recommendations for Authors Before Submission

In order to consider a manuscript, the editorial staff requires written consent of each author for processing and distribution of personal data (Download form to fill out) in printed and digital format. A scan of the signed consent form must be uploaded as an attached file in the Description section when submitting your article. Send the printed signed paper consent to the editorial office: p/o box 136, “ABV-press” publishing house”, LLC, Moscow 115522, Russiа. To the editorial office of MD-Onco Journal.

Submitting an article to for   MD-Onco  journal implies that:

• The article has not been published previously in another journal.
• The article is not under consideration in another journal.
• All co-authors agree with the current version of the article.

Before submitting an article for review, the author must ensure that the file(s) contain all the necessary information in both Russian and English, sources of information presented in figures and tables are indicated, and all citations are formatted correctly.

  MD-Onco  journal recommends authors use the following checklists and schemes developed by international health research organizations (EQUATOR Network) when preparing original articles and other materials:

During preparation of articles reflecting the results of randomized clinical trials: CONSORT 2010 checklist of information to include when reporting a randomizes trial.

During preparation of articles reflecting the results of non-experimental studies: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

During preparation of systemic reviews: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses).

During preparation of clinical case descriptions: The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development.

During preparation of articles reflecting the results of qualitative studies: SRQR (Standards for reporting qualitative research).

During preparation of articles reflecting the results of prognostic studies: STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Title Page (in both Russian and English) must include:

1. Author name(s)

According to ICMJE recommendations, only individuals who have made significant contributions to the study’s concept and design, data collection, analysis, or interpretation, and actively participated in manuscript preparation or revision, should be listed as authors. Each author must approve the final version of the article submitted for publication and agree to take responsibility for the content. Additionally, authors should be able to identify the contributions of their co-authors.

MD-Onco  journal accepts the following authorship criteria:

• Significant contribution to the study design, data collection, or data analysis and interpretation.
• Manuscript preparation or critical revision for significant intellectual content.
• Final approval of the version to be published.

The research group leader, who had the most substantial role in the study and manuscript preparation, should be listed first and is responsible for communication with the Editorial Office and readers. Upon final approval for publication, the leader must ensure that co-authors have seen and approved the final version of the manuscript.

Example of authors’ contributions:

A.M. Ivanov: study design;

V.S. Petrov, G.P. Sidorov: data acquisition, data analysis;

M.M. Ivanova: manuscript drafting;

O.D. Sidorova: literature review.

Financial support, provision of laboratory materials and tools, technical editing of the manuscript, scientific consultation, or general supervision does not justify authorship. Non-author contributors should be acknowledged in the “Acknowledgments” section.

In Russian, the surname is listed before the initials (e.g., Ivanov P.S.).

In English, the format is "First name, middle initial, surname" (e.g., Ivan I. Ivanov). Surnames in English should match those in the international passport or previous publications. If no passport or previous publications exist, use the BSI transliteration standard.

2. Author(s) information

Here titles, positions, and other credentials are listed. Must include the e-mail and full postal address of the corresponding author.

3. Author(s) affiliation

Includes the official name of the organization, complete postal address (including index, city, and country). List all relevant workplaces of each author.

If multiple institutions are involved, indicate each author’s affiliation using a superscript index.

Provide the official English name of the institution for the English section.

4. Article title

The Russian title should reflect the article’s content.

The English title should be grammatically correct and fully correspond to the Russian title in meaning.

Example:

Comprehensive Treatment of Patients with Metastatic Rectal Cancer

I.I. Ivanov¹, A.A. Petrov²

¹N.N. Blokhin National Medical Research Center of Oncology, Russia, 115478 Moscow, Kashirskoe shosse, 24;

²National Medical Research Center for Radiology, Russia, 125284 Moscow, 2nd Botkinskiy proezd, 3

Contact: Ivan Ivanovich Ivanov i.ivanov@gmail.com

5. Abstract

The recommended length is 200-250 words. The structured abstract should include sections: Aim, Methods, Results, Conclusion.

Do not introduce new terms, abbreviations (except common ones), or literature references.

6. Keywords

Provide 5-7 keywords related to the article topic. Keywords should complement the abstract and title.

7. Acknowledgments

List all funding sources and acknowledge individuals who contributed to the work but are not authors. Contributions may include research recommendations, providing research space, departmental oversight, financial support, single analyses, reagents/patients/animals/other materials. For example:

“Acknowledgements

The authors thank Prof. A.A. Ivanov for scientific consultation and revisions during manuscript preparation and Dr. V.V. Petrov for administrative support.”

Indicate whether the work received financial support, and if so, specify the source (grant, company support, etc.).

Example:

“Funding: The research was conducted without sponsor support.”

or

“Funding: The research was supported by Company N.”

“Funding: The work was financially supported by the Russian Science Foundation (grant No. 14-50-00-069).”

8. Conflict of interest

A conflict of interest is a situation in which individuals have conflicting or competing interests that could influence their editorial decision-making. Conflicts of interest can be potential or perceived, as well as real. Personal, political, financial, scientific, or religious factors can all affect objectivity.

Authors are required to disclose any real or potential conflicts of interest to the editor by including information about the conflict of interest in the appropriate section of the article.

The presence of a conflict of interest for all authors should be indicated in all articles. Conflict of interest implies the existence of any connections and/or personal interests that could potentially influence the results, interpretation of the data obtained, and their objective perception, in particular financial relationships and cooperation with any organizations (e.g., receiving royalties, educational grants, participation in expert councils, membership, employment relationships, consulting work, ownership of a privately owned store or other interests) or non-financial interests (e.g., personal or professional relationships, acquaintances, etc.) relating to the issues and/or materials discussed in the article.

If there is no conflict of interest, the author must also state this. Example of wording: “The author declares the absence of a conflict of interest.”

9. Text of the article

The IMRAD format (Introduction, Methods, Results, Discussion; Introduction, Methods, Results, Discussion) is accepted in the journal.

9.1. Text formatting

Articles are accepted in DOC, DOCX, and RTF formats. Font: Times New Roman, size 14, line spacing 1.5. All pages should be numbered. Use italics, not underlining (except for URLs) to highlight text.

9.2. Article volume (excluding illustrations and references)

Original article: no more than 12 pages (larger volumes are allowed on an individual basis, at the discretion of the editorial board). Description of clinical cases: no more than 8 pages.

Literature review: no more than 20 pages.

Brief communications and letters to the editor: 3 pages.

9.3. Article structure

An original article must contain the following sections:

• Introduction;
• Materials and methods;
• Results;
• Discussion;
• Conclusion (findings);
• Acknowledgments (this section is not mandatory).
• In addition, in accordance with Scopus and PubMed rules, the article must contain:
• Information on the contribution of all authors;
• Information on conflicts of interest;
• Information on research funding;
• Information on approval of the research protocol by the bioethics committee (for original research);
• An indication of the presence of informed consent from patients (for articles with original research and case reports);
• Information on compliance with animal rights (for articles with original research using laboratory animals).

The above information should be provided after the references.

9.4. Sections of an original article

Introduction. A brief overview of the state of the art, the reason for the need for the study, its purpose.

Materials and methods. A detailed description of all aspects of the study design: inclusion and exclusion criteria for patients, primary and secondary outcome measures, research methods, equipment used, methods and principles of group allocation, statistical analysis methods. The described research methods must guarantee the reproducibility of the results. When listing the equipment used, the manufacturer and country are indicated in brackets; when listing the drugs and chemicals used in the work, their international non-proprietary (generic) names, dosages, and routes of administration are indicated. If the study requires it, indicate by which ethics committee it was approved (quote its conclusion, indicating the document number, date of its signing, and the official name of the ethics committee), the fact that the subjects signed informed consent, or the fact that bioethical principles were observed (animal rights).

Results. Should be presented in a logical sequence, reflecting the data of the study described above without references to literature sources. The results are presented clearly, in the form of short descriptions with references to graphs, tables, and figures. The section is preferably started with a graph demonstrating the patient selection for analysis (patient flow chart) to explain the formation of the study group.

Discussion. Highlighting new and important aspects based on the results of the study, analysis of possible mechanisms or interpretation of the results obtained, comparison of their own results with the data of other researchers. It is possible to include reasoned recommendations for clinical practice and the application of the data obtained in future research. The section should end with a statement of the strengths and weaknesses of the study in comparison with existing analogues. Avoid repeating information from the Introduction section and a detailed listing of data from the Results section.

Conclusion. Should be short and concise (no more than 1 paragraph). Summarizing the work done and the authors’ hypothesis about the significance of the data obtained in the context of pathogenesis, treatment, diagnosis; prospects for using the data obtained.

9.5. Compliance with patient rights and bioethical principles

For an original study, it is necessary to indicate whether its protocol complied with ethical principles and by which ethics committee the study was approved (indicating the document number, date of its signing, and the official name of the committee).

Patients have the right to privacy, which cannot be disclosed without their consent. Personally identifiable information, including patient names and initials, hospital numbers, and medical records, should not be published in the form of written descriptions, photographs, or pedigrees, unless it is of great scientific value or unless the patient (or their parent/guardian) provides written consent for publication. In such cases, the authors must inform the patients of the possibility that their identifiable information may become available online after publication. For the publication of the results of an original work, the authors must provide the Editorial Board with written informed consent from the patient(s) for the dissemination of the information and report this in the article, placing the following statement after the list of references:

“Compliance with patient rights and bioethical principles The research protocol was approved by the Biomedical Ethics Committee <…>. All patients signed informed consent to participate in the study.”

If children were included in the study:

“Compliance with patient rights and bioethical principles The research protocol was approved by the Biomedical Ethics Committee <…>. The parents of the patients signed informed consent for the children to participate in the study.”

If the article includes a case report:

“Compliance with patient rights. The patient(s) signed informed consent for the publication of their data.”

If the patient is under 18 years of age:

“Compliance with patient rights. The parents of the patient(s) signed informed consent for the publication of his/her data.”

If laboratory animals were used in the study, it must be indicated whether the study protocol complied with the standards for conducting biomedical research involving animals:

“Compliance with bioethical principles The research protocol was approved by the Ethics Committee of <name of the institution of the first author>. The study was conducted in accordance with the ethical standards for animal care adopted by the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes.”

9.6. Units of measurement and abbreviations

Units of measurement should be given in the International System of Units (SI). If the study was conducted on instruments that provide readings in other units, they should be converted to the SI system with an indication of the conversion factor or computer program in the “Materials and Methods” section.

Abbreviations of words are not allowed, except for generally accepted ones. All abbreviations in the text of the article must be fully expanded at the first mention, for example: neuromuscular diseases (NMD).

Gene names should be italicized, protein names should be in regular font.

10. Figures

Figures should be of good quality and suitable for printing. All figures must have captions. The caption must be translated into English. Figures are numbered with Arabic numerals in order of appearance in the text. If there is only one figure in the text, it is not numbered. References to figures are formatted as follows: “Figure 3 shows that ...” or “It is stated that ... (see Figure 3)”. The caption includes the figure number and its title. It is centered: “Figure 2. Description of vital processes”. A period is not placed after the caption. The translation of the caption should be placed after the caption in Russian.

11. Tables

Tables should be of good quality and suitable for printing. Tables that can be edited are preferred, rather than scanned tables or tables in the form of figures. All tables must have titles. The table title must be translated into English. Tables are numbered with Arabic numerals in order of appearance in the text. If there is only one table in the text, it is not numbered. References to tables are formatted as follows: “Table 3 shows that ...” or “It is stated that ... (see Table 3)”. The table title includes the table number and its title. “Table 2. Description of vital processes”. A period is not placed after the table title. The translation of the table title should be placed after the table title in Russian.

12. Screenshots and photographs

Photographs, screenshots, and other non-drawn illustrations must be uploaded separately in a special section of the article submission form as files in *.jpeg, *.bmp, *.gif (*.doc and *.docx – if additional marks are applied to the image). The image resolution must be >300 dpi. Image files must be named according to the figure number in the text. The file description should separately include the caption, which must correspond to the name of the photograph placed in the text.

13. Footnotes

Footnotes are numbered with Arabic numerals and are placed on a per-page basis. Footnotes can be used for: references to anonymous sources on the Internet, references to textbooks, teaching aids, GOSTs, statistical reports, articles in socio-political newspapers and magazines, author’s abstracts, dissertations (if there is no possibility to cite articles published based on the dissertation research), author’s comments.

14. References

The journal uses the Vancouver citation format, which implies a reference to the source in square brackets and subsequent mention of the sources in the list of references in the order of mention. The page is indicated in brackets, separated by a comma and a space after the source number: [6, p. 8].

Only peer-reviewed sources (articles from scientific journals and monographs) mentioned in the text of the article are included in the list of references. It is undesirable to include author’s abstracts, dissertations, textbooks, teaching aids, GOSTs, information from websites, statistical reports, articles in socio-political newspapers, on websites and in blogs in the list of references. If it is necessary to refer to such information, the information about the source should be placed in a footnote.

When describing a source, its DOI should be indicated if it can be found (for foreign sources, it can be done in 95% of cases).

Links to accepted for publication, but not yet published articles should be marked with the words “in press”; authors must obtain written permission to link to such documents and confirmation that they are accepted for publication. Information from unpublished sources should be marked with the words “unpublished data/documents”; authors must also obtain written confirmation to use such materials.

Links to articles from journals must indicate the year of publication, volume and issue of the journal, page numbers.

All authors must be listed in the description of each source.

Links must be verified, the output data must be checked on the official website of the journals and/or publishers.

A translation of the list of references into English is required. After the description of the Russian-language source, an indication of the language of the work is placed at the end of the link: (In Russ.).

To transliterate the names and surnames of authors, the names of journals, the BSI standard should be used.

Examples of Formatting

References to articles from foreign sources:

1Surname I.O., 2Surname I.O. Title of article. Title of journal. Year;Volume (Issue):Pages(00–00). DOI: 10.13655/1.6.1234567

References to monographs in a foreign language:

With 1–3 authors:

1Surname I.O., 2Surname I.O. Title of book. Edition number. City: Publisher; Year of publication.

Indication of the editor or compiler:

1Surname I.O., 2Surname I.O., 3Surname I.O., editors. Title. Edition number. City: Publisher; Year of publication.

Chapter from a monograph or collection:

1Surname I.O. Title. In: 2Surname I.O., editor. 2Title. Edition number. City: Publisher; Year of publication. Pages 00–00.

Formatting of translated references to an article and a monograph

In general, the structure of a reference to an article looks like this:

Authors (transliteration). [Translation of the article title into English in square brackets]. Title of the Russian-language source (transliteration). Output data with an indication in English or only digital. Indication of the language of the article (In Russ.)

In general, the structure of a reference to a monograph looks like this:

Authors (transliteration). [Translation of the title of the monograph in square brackets]. Output data: place of publication in English, if it is an organization, and transliteration, if the publisher has its own name (with an indication in English that it is a publisher). Number of pages.

Links to Internet resources:

Note. It is preferable to indicate a link to the material from the website that is mentioned in the article. A link to the main page is not informative and does not make it possible to verify the information.

Title of the material on the site [site]. Site name; 2016 [updated October 19, 2016; accessed October 30, 2016]. Available at: http://www.example.ru

II. How to submit an article for review

The manuscript of the article is submitted to the Editorial Board through the online form. The file with the article to be uploaded to the system must be presented in Microsoft Word format (have an extension *.doc, *.docx, *.rtf).

III. Interaction between the journal and the author

The Editorial Board of the journal corresponds with the responsible (corresponding) author, however, at the request of the team of authors, letters can be sent to all authors for whom an email address is indicated.

All articles received by MD-Onco  journal undergo preliminary review by the executive secretary of the journal for compliance with formal requirements. At this stage, the article may be returned to the author(s) for revision with a request to correct errors or add missing data. Also at this stage, the article may be rejected due to its non-compliance with the goals of the journal, lack of originality, or low scientific value.

After preliminary review, the executive editor sends the article to the reviewer with the deadlines for review. The author is sent a corresponding notification.

In controversial cases, the editor may involve several specialists, as well as the Editor-in-Chief, in the review process.

If the reviewer’s conclusion is positive, the article is sent to the editor for preparation for publication.

When making a decision to revise the article, the reviewer’s comments and comments are sent to the author. The author is given 2 months to eliminate the comments. If during this period the author does not notify the Editorial Board of the planned actions, the article is removed from the publication queue.

When making a decision to refuse to publish an article, the author is sent a corresponding decision of the Editorial Board.

The responsible (corresponding) author of the accepted article is sent the final version of the layout, which he is obliged to check. The response is expected from the authors within 2 days. If there is no response from the author, the layout of the article is considered approved.

IV. Procedure for revising decisions of the editor/reviewer

If the author does not agree with the conclusion of the reviewer and/or editor or with individual comments, they can dispute the decision made. To do this, the author needs to:

• Correct the manuscript of the article according to the justified comments of reviewers and editors;
• Clearly state their position on the issue under consideration.

The editors assist in the resubmission of manuscripts that could potentially be accepted, but were rejected due to the need for significant changes or the collection of additional data, and are ready to explain in detail what needs to be corrected in the manuscript in order for it to be accepted for publication.

V. Actions of the Editorial Board in case of detection of plagiarism, fabrication or falsification of data

In case of detection of dishonest behavior on the part of the author, detection of plagiarism, fabrication or falsification of data, the Editorial Board is guided by the rules of COPE.

By “dishonest behavior” MD-Onco  journal understands any actions of the scientist, including improper handling of objects of study or intentional manipulation of scientific information, in which it ceases to reflect the observed studies, as well as the behavior of the scientist that does not correspond to accepted ethical and scientific standards.

MD-Onco  journal does not consider honest mistakes or honest discrepancies in the plan, conduct, interpretation or evaluation of research methods or results, as well as dishonest behavior not related to the scientific process, to be “dishonest behavior”.

VI. Correction of errors and withdrawal of an article

If errors are found in the text of the article that affect its perception, but do not distort the presented research results, they can be corrected by replacing the pdf-file of the article and indicating the error in the article file itself and on the article page on the journal website.

If errors are found in the text of the article that distort the research results, or in case of plagiarism, detection of dishonest behavior of the author(s) associated with falsification and/or fabrication of data, the article may be withdrawn. The initiator of the withdrawal of the article may be the Editorial Board, author, organization, private person.

The withdrawn article is marked with the sign “Article withdrawn”, information about the reason for the withdrawal of the article is posted on the article page. Information about the withdrawal of the article is sent to the databases in which the journal is indexed.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

1. The manuscripts are accepted if has not been published or submitted for publication elsewhere.

2. The materials should be prepared in a format OpenOffice, Microsoft Word, RTF, or World Perfect.

3. Internet links are provided as a complete URL. 

4. Text should be typed with an interval of one and a half line spacing, font Times New Roman, 14 pt; to highlight the accents it is recommended to use italics rather than underlining (except Internet links). All images, graphics and tables are placed within the text according to the meaning of the particular part of text  (and not at the end of the document).

5. Text should follow the stylistic and bibliography requirements as stated in  Regulations  located in the Part "About Us." 

6. Please, remove the authors' names from the title of the article and other parts of the document to ensure the  anonymity of reviewing.

Copyright Notice

Authors who publish with “MD-Onco” journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the workʼs authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).

Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.